JANX short interest
Janux Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 5,684,346 |
|---|---|
| Change vs prior report | -207,619 (-3.5%) |
| Change over six months | -26.6% |
| Days to cover | 5.86 (sector: 3.78) |
| Average daily volume | 969,533 |
| Rank in Healthcare | #338 of 922 by days to cover |
JANX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 5,684,346 | -3.5% | 5.86 | 969,533 |
| 2026-09-15 | 5,891,965 | -2.8% | 5.89 | 999,885 |
| 2026-08-31 | 6,063,535 | -8.5% | 7.81 | 776,426 |
| 2026-08-14 | 6,626,696 | +11.9% | 10.90 | 607,942 |
| 2026-07-31 | 5,922,899 | -8.2% | 7.74 | 765,256 |
| 2026-07-15 | 6,454,019 | -9.2% | 6.43 | 1,003,518 |
| 2026-06-30 | 7,108,085 | -6.7% | 3.59 | 1,978,810 |
| 2026-06-15 | 7,615,380 | -5.9% | 10.96 | 694,792 |
| 2026-05-29 | 8,091,847 | +3.4% | 6.83 | 1,184,704 |
| 2026-05-15 | 7,827,096 | -1.3% | 9.66 | 810,461 |
| 2026-04-30 | 7,932,981 | +6.6% | 7.40 | 1,072,535 |
| 2026-04-15 | 7,440,069 | -3.9% | 8.27 | 900,076 |
| 2026-03-31 | 7,744,629 | -22.7% | 5.51 | 1,405,554 |
| 2026-03-13 | 10,020,131 | +0.2% | 12.01 | 833,971 |
| 2026-02-27 | 9,996,191 | -1.5% | 12.52 | 798,369 |
| 2026-02-13 | 10,144,569 | -3.2% | 7.38 | 1,375,257 |
| 2026-01-30 | 10,476,584 | +10.9% | 5.58 | 1,877,069 |
| 2026-01-15 | 9,444,405 | +2.2% | 6.36 | 1,483,872 |
| 2025-12-31 | 9,239,650 | +24.9% | 3.50 | 2,641,124 |
| 2025-12-15 | 7,395,136 | -2.8% | 1.98 | 3,732,771 |
| 2025-11-28 | 7,606,181 | +6.7% | 6.91 | 1,100,209 |
| 2025-11-14 | 7,131,951 | +2.7% | 6.84 | 1,042,069 |
| 2025-10-31 | 6,946,508 | -18.9% | 5.80 | 1,197,554 |
| 2025-10-15 | 8,562,496 | -4.1% | 8.22 | 1,042,241 |
| 2025-09-30 | 8,932,119 | +7.6% | 10.88 | 820,902 |
import finzdata as yf
yf.Ticker("JANX").short_interest # every report since 2017
yf.Client().short_interest(["JANX"], start="2018-01-01")Healthcare short interest · JANX price history · Who owns JANX · All short interest